Récipiendaires de la Bourse de recherche sur la fibrillation auriculaire SCC/Bristol-Myers Squibb-Pfizer
2021
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
William McIntyre | Short Term Anti-arrythmic Therapy for Post-operative AF in Cardiac Surgery Patients: START-POAF Pilot Trial | $90,000 |
Wendy Tsang | Atrial Fibrillation Incidence, Outcomes, and Left Atrial Morphology in Immigrants | $90,000 |
Nathaniel Hawkins & Marc Deyell  | Atrial Ectopy for the Prediction of Incident Atrial Fibrillation | $90,000 |
2020
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Julia Cadrin-Tourigny & Rafik Tadros | Atrial Fibrillation Screening Based on Genetic Risk: The Gene AF Study | $95,000 |
| Hussam Abdel-Qadir & Dennis Ko | The Secondary Atrial Fibrillation Evaluation (SAFE) Study | $95,000 |
2019
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Jodi Edwards & Thais Coutinho | Do Hypertensive Disorders of Pregnancy Increase the Risk of Incident Atrial Fibrillation? | $66,014 |
| Nathaniel M. Hawkins & Christopher B. Fordyce | Opportunities to Prevent Sudden Cardiac Death: The BC Cardiac Arrest Registry | $19,824 |
| Krystina B. Lewis | Identifying Effective Strategies to Engage Patients in Making Decisions Along the ICD Care Pathway: A Multi-province Comparative Case Study | $57,584 |
| Mouhannad M. Sadek | Non-Invasive Evaluation of Pulmonary Vein Isolation | $67,442 |
| Emilie Belley-Côté | Direct Oral Anticoagulation versus Warfarin after Cardiac Surgery (DANCE) Pilot Trial | $64,395 |
2018
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Andrew Ha & Douglas Lee | Association Between Oral Anticoagulation Use and Outcomes for Older Patients with New Onset Post-operative Atrial Fibrillation After Cardiac Surgery: A Population-based Analysis from Ontario, Canada | $100,000 |
| Jacqueline Joza & Jonathan Afilalo | Association of Muscle Mass with Direct Oral Anticoagulant Activity in Older Adults | $100,000 |
| Jorge Wong & Stuart Connolly | Subclinical Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction and the Risk of Heart Failure Re-hospitalization | $100,000 |
2017
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Husam-Eldin Mohamed Abdel-Qadir | Atrial Fibrillation After Early Stage Breast Cancer: Incidence, Risk Factors, Pathogenesis, and Impact | $100,000 |
| Rafik Tadros | Atrial Fibrillation-associated Cardiomyopathy: Genetic Basis and Prognostic Implications | $100,000 |
| Ratika Parkash | Reversal of Atrial Substrate to Prevent Atrial Fibrillation (RASTA-AF) | $100,000 |
2016
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Jason Roberts | Efficacy, Health Care Utilization Rates and Safety of a Same-day Discharge Protocol for AF Ablations | $100,000 |
| William McIntyre & Jeff Healey | Atrial Fibrillation Occurring Transiently with Stress (AFOTS) Understanding the Risks of Recurrent AF in Non-cardiac Surgery | $100,000 |
| Philip Joseph | A Multi-national Study to Understand the Upstream Risk Factors for Atrial Fibrillation | $100,000 |
2015
| Chercheurs principaux | Titres des propositions | Montants des bourses |
|---|---|---|
| Marc Deyell | Efficacy, Health Care Utilization Rates and Safety of a Same-day Discharge Protocol for AF Ablations | $100,000 |
| Duncan Stewart | Circulating MicroRNAs as Non-invasive Biomarkers to Improve the Diagnosis of Paroxysmal Atrial Fibrillation | $100,000 |
| Peter Loewen | Long-term Persistence and Adherence with New Oral Anticoagulants vs. Warfarin in Newly-anticoagulated Atrial Fibrillation Patients | $100,000 |